Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

DMII

Drugs Made In America Acquisition II Corp

10.14

Aug 07 • 10:16 AM ET +0.02 (0.19%)

Financial Shell Companies USA Small NASD

Held by: SPCK

Index	-
Market Cap	644.96M
Enterprise Value	645.06M
Income	8.58M
Sales	0.00M
Book/sh	7.72
Cash/sh	0.01
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	2
IPO	Dec 03, 2025

P/E	75.67
Forward P/E	-
PEG	-
P/S	-
P/B	1.31
P/C	1842.74
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.53
Current Ratio	0.53
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	0.13
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	7666.67%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	22.15%
Insider Trans	0.00%
Inst Own	68.83%
Inst Trans	-
ROA	3.37%
ROE	3.49%
ROIC	1.75%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	0.38%
SMA50	0.54%
SMA200	1.39%
Trades

Shs Outstand	63.70M
Shs Float	49.59M
Short Float	0.09%
Short Ratio	0.58
Short Interest	0.05M
52W High	10.20 -0.60%
52W Low	9.86 2.83%
Volatility	0.04% 0.14%
ATR (14)	0.02
RSI (14)	69.14
Beta	-
Rel Volume	0.00
Avg Volume	79.51K
Volume	6

Perf Week	0.29%
Perf Month	0.39%
Perf Quarter	1.24%
Perf Half Y	1.29%
Perf YTD	2.42%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	10.12
Price	10.14
Change %	0.19%

Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in New York, NY.

Chief Executive OfficerMr. Roger Bendelac

CFO & Principal Accounting OfficerMr. Saleem Elmasri CPA

Open in Screener

DMAA

Drugs Made In America Acquisition Corp

10.70

Aug 07 • 12:30 PM ET -0.01 (-0.05%)

10.72

Aftermarket • 4:15 PM ET +0.02 (0.14%)

Financial Shell Companies USA Micro NASD

DMAA Drugs Made In America Acquisition Corp daily Stock Chart

Index	-
Market Cap	259.88M
Enterprise Value	259.97M
Income	6.66M
Sales	0.00M
Book/sh	6.96
Cash/sh	0.00
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	2
IPO	Feb 25, 2025

P/E	54.01
Forward P/E	-
PEG	-
P/S	-
P/B	1.54
P/C	25988.00
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.03
Current Ratio	0.03
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	0.20
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	602.84%
Sales Y/Y TTM	-
EPS Q/Q	56.15%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	23.57%
Insider Trans	0.00%
Inst Own	93.48%
Inst Trans	-
ROA	2.80%
ROE	2.89%
ROIC	2.84%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	0.16%
SMA50	0.54%
SMA200	2.26%
Trades

Shs Outstand	33.72M
Shs Float	18.56M
Short Float	0.51%
Short Ratio	2.46
Short Interest	0.09M
52W High	10.72 -0.14%
52W Low	10.22 4.75%
Volatility	0.03% 0.15%
ATR (14)	0.02
RSI (14)	64.45
Beta	0.01
Rel Volume	0.03
Avg Volume	38.09K
Volume	1,111

Perf Week	-0.05%
Perf Month	0.47%
Perf Quarter	0.99%
Perf Half Y	2.64%
Perf YTD	3.19%
Perf Year	4.24%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	10.71
Price	10.70
Change %	-0.05%

Drugs Made In America Acquisition Corp. is a blank check company, which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in New York, NY.

Chief Executive OfficerMr. Roger Bendelac

CFO & Principal Accounting OfficerMr. Saleem Elmasri CPA

DMII

Drugs Made In America Acquisition II Corp

DMAA

Drugs Made In America Acquisition Corp

Upgrade your Finviz experience